经胃镜做食管内支架置入术治疗食管癌伴狭窄的临床效果观察  

Clinical effect of endoscopic esophageal stenling in the treatment of esophageal carcinoma with stenosis

作　　者：邰力艾提·阿不都热依木[1] 

机构地区：[1]新疆医科大学附属肿瘤医院,新疆乌鲁木齐830011

出　　处：《医药前沿》2016年第9期21-23,共3页Journal of Frontiers of Medicine

摘　　要：目的：对经胃镜食管内支架置入术（EESI）治疗食管癌伴食管狭窄（ECS）的临床疗效进行评价、观察。方法：将我院在2012年2月-2013年5月间行EESI手术＋化疗的28例ECS病例作手术组，选择同时期在我院采用放疗＋化疗治疗的25例ECS患者作放疗组，对比两组的相关治疗指标、术后并发症、生存期情况。结果：短期疗效方面，治疗后1个月手术组的总有效率、食管狭窄口径、并发症发生率、病情复发率等均显著优于放疗组（P〈0．05）。生存期方面，手术组存活2年以上13例（占46．4％），放疗组存活2年以上4例（占16．0％），经比较差异有统计学意义（P〈0．05）。结论：EESI手术具有微创无痛、成功率高、疗效确切、并发症少、操作方便、适用范围广等优势，值得在晚期食管癌（特别是ECS病变）的临床治疗中借鉴、应用。Objective To observe the clinical efficacy of endoscopic esophageal stenting （EESI） for esophageal carcinoma with esophageal stenosis （ECS）. Methods 28 cases of ECS were treated from February 2012 to May 2013 in our hospital, and 25 patients with ECS were treated with radiotherapy and chemotherapy. The patients were followed up until now. The correlation between the two groups was compared with the groups. Results The short-term efficacy, the total effective rate, the esophageal stenosis caliber, the complication rate and the recurrence rate of the treatment group were significantly higher than that of the radiotherapy group （P 〈 0.05）. Survival period, the survival of the surgical group for more than 13 years in 2 cases （46.4%）, radiotherapy group for 2 years, 4 cases （16%）, the difference was statistically significant （P 〈 0.05）. Conclusion EESI operation has the advantages of minimally invasive painless, high success rate, definite curative effect, less complications, convenient operation, wide application, etc. it is worthy of reference and application in the clinical treatment of advanced esophageal carcinoma （especially ECS lesions）.

关 键 词：EBSI ECS 疗效 分析观察 

分 类 号：R573[医药卫生—消化系统]